Claudia Buerger

1.2k total citations
25 papers, 929 citations indexed

About

Claudia Buerger is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Claudia Buerger has authored 25 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Oncology. Recurrent topics in Claudia Buerger's work include Psoriasis: Treatment and Pathogenesis (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Claudia Buerger is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (7 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Claudia Buerger collaborates with scholars based in Germany, Switzerland and Austria. Claudia Buerger's co-authors include Vuk Stambolic, Ben DeVries, Bernd Groner, Wolf‐­Henning Boehncke, Kerstin Nagel‐Wolfrum, Karin Butz, Ilka Wittig, Felix Hoppe‐Seyler, Katja Hardt and Sandra Diehl and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Claudia Buerger

25 papers receiving 914 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claudia Buerger Germany 14 514 267 172 169 138 25 929
Yitang Li United States 11 322 0.6× 309 1.2× 80 0.5× 98 0.6× 148 1.1× 12 762
Elmar vom Baur France 9 598 1.2× 358 1.3× 159 0.9× 143 0.8× 31 0.2× 14 1.0k
Randall Evans United States 13 609 1.2× 117 0.4× 220 1.3× 157 0.9× 124 0.9× 24 991
Eriko Aizu-Yokota Japan 14 477 0.9× 130 0.5× 120 0.7× 65 0.4× 134 1.0× 20 848
Luowei Li United States 18 852 1.7× 118 0.4× 199 1.2× 77 0.5× 282 2.0× 29 1.2k
Marion Leduc France 15 258 0.5× 172 0.6× 207 1.2× 111 0.7× 93 0.7× 34 786
Werner Bollag Switzerland 14 918 1.8× 211 0.8× 157 0.9× 126 0.7× 104 0.8× 25 1.2k
Nihal Kaplan United States 18 465 0.9× 150 0.6× 74 0.4× 57 0.3× 127 0.9× 39 1.0k
Daniel DiSepio United States 11 431 0.8× 140 0.5× 75 0.4× 65 0.4× 87 0.6× 14 744
Lidia Avalle Italy 17 519 1.0× 413 1.5× 491 2.9× 67 0.4× 60 0.4× 25 1.1k

Countries citing papers authored by Claudia Buerger

Since Specialization
Citations

This map shows the geographic impact of Claudia Buerger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Buerger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Buerger more than expected).

Fields of papers citing papers by Claudia Buerger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Buerger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Buerger. The network helps show where Claudia Buerger may publish in the future.

Co-authorship network of co-authors of Claudia Buerger

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Buerger. A scholar is included among the top collaborators of Claudia Buerger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Buerger. Claudia Buerger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buerger, Claudia, et al.. (2025). RNAi-based ALOX15B silencing augments keratinocyte inflammation in vitro via EGFR/STAT1/JAK1 signalling. Cell Death and Disease. 16(1). 39–39. 2 indexed citations
2.
Lang, Victoria, et al.. (2023). Different immortalized keratinocyte cell lines display distinct capabilities to differentiate and reconstitute an epidermis in vitro. Experimental Dermatology. 33(1). e14985–e14985. 5 indexed citations
3.
4.
Heck, Susanne, Tiziana Cesetti, Rüdiger Rudolf, et al.. (2023). The Ca2+ channel TRPV4 is dispensable for Ca2+ influx and cell volume regulation during hypotonic stress response in human keratinocyte cell lines. Cell Calcium. 111. 102715–102715. 4 indexed citations
5.
Lang, Victoria, et al.. (2022). mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex. Cells. 11(18). 2847–2847. 5 indexed citations
6.
König, Arne, Victoria Lang, Sandra Diehl, et al.. (2021). mTORC1 – a potential player in the pathogenesis of hidradenitis suppurativa?. Journal of the European Academy of Dermatology and Venereology. 35(7). e444–e447. 7 indexed citations
7.
Rauh, Oliver, et al.. (2021). Cell Volume Regulation in the Epidermis. Cellular Physiology and Biochemistry. 55(S1). 57–70. 8 indexed citations
8.
Borowczyk, Julia, Claudia Buerger, Justyna Drukała, et al.. (2020). IL-17E (IL-25) and IL-17A Differentially Affect the Functions of Human Keratinocytes. Journal of Investigative Dermatology. 140(7). 1379–1389.e2. 35 indexed citations
9.
Buerger, Claudia. (2018). Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target. Frontiers in Immunology. 9. 2786–2786. 69 indexed citations
10.
Lang, Victoria, Paul Scholz, Ümit Pul, et al.. (2018). Hypotonic stress response of human keratinocytes involves LRRC8A as component of volume‐regulated anion channels. Experimental Dermatology. 27(12). 1352–1360. 19 indexed citations
11.
Buerger, Claudia, Victoria Lang, Sandra Diehl, et al.. (2017). Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation. PLoS ONE. 12(7). e0180853–e0180853. 65 indexed citations
12.
Lang, Victoria, et al.. (2016). 357 Blocking mTOR signaling with rapamycin ameliorates imiquimod-induced psoriasis in mice. Journal of Investigative Dermatology. 136(9). S221–S221. 2 indexed citations
13.
Boehncke, Wolf‐­Henning, Sandra Boehncke, & Claudia Buerger. (2012). Jenseits der Immunpathogenese. Der Hautarzt. 63(3). 178–183. 4 indexed citations
14.
Buerger, Claudia, Beatrice Richter, R. Salgo, et al.. (2012). Interleukin-1β Interferes with Epidermal Homeostasis through Induction of Insulin Resistance: Implications for Psoriasis Pathogenesis. Journal of Investigative Dermatology. 132(9). 2206–2214. 83 indexed citations
15.
Marshall, Christopher B., Jason Ho, Claudia Buerger, et al.. (2009). Characterization of the Intrinsic and TSC2-GAP–Regulated GTPase Activity of Rheb by Real-Time NMR. Science Signaling. 2(55). ra3–ra3. 54 indexed citations
16.
Boehncke, Wolf‐­Henning, Claudia Buerger, & Sandra Boehncke. (2009). Komorbiditäten bei Psoriasis vulgaris. Der Hautarzt. 60(2). 116–121. 13 indexed citations
17.
Künz, Christian, Corina Borghouts, Claudia Buerger, & Bernd Groner. (2006). Peptide Aptamers with Binding Specificity for the Intracellular Domain of the ErbB2 Receptor Interfere with AKT Signaling and Sensitize Breast Cancer Cells to Taxol. Molecular Cancer Research. 4(12). 983–998. 29 indexed citations
18.
Buerger, Claudia, Ben DeVries, & Vuk Stambolic. (2006). Localization of Rheb to the endomembrane is critical for its signaling function. Biochemical and Biophysical Research Communications. 344(3). 869–880. 156 indexed citations
19.
Buerger, Claudia & Bernd Groner. (2003). Bifunctional recombinant proteins in cancer therapy: cell penetrating peptide aptamers as inhibitors of growth factor signaling. Journal of Cancer Research and Clinical Oncology. 129(12). 669–675. 25 indexed citations
20.
Buerger, Claudia, Kerstin Nagel‐Wolfrum, Christian Künz, et al.. (2003). Sequence-specific Peptide Aptamers, Interacting with the Intracellular Domain of the Epidermal Growth Factor Receptor, Interfere with Stat3 Activation and Inhibit the Growth of Tumor Cells. Journal of Biological Chemistry. 278(39). 37610–37621. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yitang Li Breakdown of academic impact, for papers by Elmar vom Baur Breakdown of academic impact, for papers by Randall Evans Breakdown of academic impact, for papers by Eriko Aizu-Yokota Breakdown of academic impact, for papers by Luowei Li Breakdown of academic impact, for papers by Marion Leduc Breakdown of academic impact, for papers by Werner Bollag Breakdown of academic impact, for papers by Nihal Kaplan Breakdown of academic impact, for papers by Daniel DiSepio Breakdown of academic impact, for papers by Lidia Avalle
Rankless by CCL
2026